Wyeth Explains Prevnar Allocation System
Executive Summary
In a Feb. 12 1letter to practitioners, Wyeth explained its plans for allocating supplies of the pneumococcal conjugate vaccine Prevnar until manufacturing delays are resolved. The allocation program is based on monthly purchase history and reflects updated recommendations by CDC on delaying administration of the fourth dose in the series (2"The Pink Sheet" Feb. 16, 2004, p. 20).